1-oxa-4,7,10,13-tetraaza-cyclopentadecane | 40826-34-4

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 1-oxa-4,7,10,13-tetraaza-cyclopentadecane
• 英文别名: [15]ane-ON₄；1-oxa-4,7,10,13-tetraazacyclopentadecane；Oxatetraazacyclopentadecan；15-crown-ON₄；1-oxa-4,7,10,13-tetrazacyclopentadecane
• CAS: 40826-34-4
• 化学式: C₁₀H₂₄N₄O
• 分子量: 216.327
• InChiKey: PBMRYHIUXYUSGB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -2.1
• 重原子数：
  15
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  57.4
• 氢给体数：
  4
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  4,7,10,13-tetrakis-(toluene-4-sulfonyl)-1-oxa-4,7,10,13-tetraaza-cyclopentadecane 在 硫酸 作用下， 生成 1-oxa-4,7,10,13-tetraaza-cyclopentadecane
  参考文献：
  名称：

  Rasshofer,W.; Voegtle,F., Justus Liebigs Annalen der Chemie, 1977, p. 1340 - 1343

  摘要：

  DOI：

文献信息

• Methods of preparing manganese complexes of nitrogen-containing
  申请人：Monsanto Company

  公开号：US05610293A1

  公开（公告）日：1997-03-11

  The present invention is directed to low molecular weight mimics of superoxide dismutase (SOD) represented by the formula: ##STR1## wherein R, R', R.sub.1, R'.sub.1, R.sub.2, R'.sub.2, R.sub.3, R'.sub.3, R.sub.4, R'.sub.4, R.sub.5, R'.sub.5, R.sub.6, R'.sub.6, R.sub.7, R'.sub.7, R.sub.8, R'.sub.8, R.sub.9, and R'.sub.9 and X, Y, Z and n are as defined herein, useful as therapeutic agents for inflammatory disease states and disorders, ischemic/reperfusion injury, stroke, atherosclerosis, hypertension and all other conditions of oxidant-induced tissue damage or injury.

  本发明涉及超氧化物歧化酶（SOD）的低分子量模拟物，其表示为以下式子：##STR1## 其中R，R'，R1，R'1，R2，R'2，R3，R'3，R4，R'4，R5，R'5，R6，R'6，R7，R'7，R8，R'8，R9和R'9以及X，Y，Z和n如本文所定义，可用作治疗炎症性疾病状态和障碍，缺血/再灌注损伤，中风，动脉硬化，高血压以及所有其他氧化剂引起的组织损伤或损伤的治疗剂。
• Manganese complexes of nitrogen-containing macrocyclic ligands effective
  申请人：——

  公开号：US05637578A1

  公开（公告）日：1997-06-10

  The present invention is directed to low molecular weight mimics of superoxide dismutase (SOD) represented by the formula: ##STR1## wherein R, R', R.sub.1, R'.sub.1, R.sub.2, R'.sub.2, R.sub.3, R'.sub.3, R.sub.4, R'.sub.4, R.sub.5, R'.sub.5, R.sub.6, R'.sub.6, R.sub.7, R'.sub.7, R.sub.8, R'.sub.8, R.sub.9, and R'.sub.9 and X, Y, Z and n are as defined herein, useful as therapeutic agents for inflammatory disease states and disorders, ischemic/reperfusion injury, stroke, atherosclerosis, hypertension and all other conditions of oxidant-induced tissue damage or injury.

  本发明涉及超氧化物歧化酶（SOD）的低分子量模拟物，其化学式为：##STR1## 其中R、R'、R1、R'1、R2、R'2、R3、R'3、R4、R'4、R5、R'5、R6、R'6、R7、R'7、R8、R'8、R9和R'9以及X、Y、Z和n的定义如本文所述，作为治疗炎症性疾病状态和紊乱、缺血/再灌注损伤、中风、动脉粥样硬化、高血压以及其他氧化剂引起的组织损伤或损伤的治疗剂使用。
• IMAGING CONTRAST AGENTS AND USES THEREOF
  申请人：Morrow Janet R.

  公开号：US20140193344A1

  公开（公告）日：2014-07-10

  Provided are macrocyclic compounds having a macrocyclic core which has at least one macrocyclic donor and at least one pendant group which has at least one donor group. The macrocyclic compounds can be complexed to Fe(II) and Ni(II). The macrocyclic compounds can be used in imaging methods. For example, the compounds can be used MRI paraCEST contrast agents.

  提供的是具有至少一个大环供体和至少一个带有至少一个供体基团的挂基团的大环化合物的大环核。这些大环化合物可以与Fe（II）和Ni（II）形成络合物。这些大环化合物可以用于成像方法。例如，这些化合物可以用于MRI paraCEST对比剂。
• MACROCYCLES, COBALT AND IRON COMPLEXES OF SAME, AND METHODS OF MAKING AND USING SAME
  申请人：The Research Foundation for The State University of New York

  公开号：US20160228581A1

  公开（公告）日：2016-08-11

  Provided are macrocyclic compounds and iron or cobalt coordinated macrocyclic compounds. The compounds can be used as MRI contrast agents. Certain compounds are redox active and can be used to assess the biological redox status of a sample.

  提供的是大环化合物以及铁或钴配位的大环化合物。这些化合物可以用作MRI对比剂。某些化合物是氧化还原活性的，可以用于评估样品的生物氧化还原状态。
• Manganese complexes of nitrogen containing macrocyclic ligands effective as catalysts for dismutating superoxide
  申请人：MONSANTO COMPANY

  公开号：EP0524161A1

  公开（公告）日：1993-01-20

  The present invention is directed to low molecular weight mimics of superoxide dismutase (SOD) represented by the formula: wherein R, R′, R₁, R′₁, R₂, R′₂, R₃, R′₃, R₄, R′₄, R₅, R′₅, R₆, R′₆, R₇, R′₇, R₈, R′₈, R₉, and R′₉ and X, Y, Z and n are as defined herein, useful as therapeutic agents for inflammatory disease states and disorders, ischemic/reperfusion injury, stroke, atherosclerosis, hypertension and all other conditions of oxidant-induced tissue damage or injury.

  本发明涉及由式表示的超氧化物歧化酶（SOD）的低分子量模拟物： 其中 R、R′、R₁、R′₁、R₂、R′₂、R₃、R′₃、R′₄、R′₄、R₅、R′₅、R₆、R′₆、R₇、R′₇、R₈、R₉、R₉ 和 R′₉ 以及 X、Y、Z 和 n 如本文所定义、可用作炎症性疾病和失调、缺血/再灌注损伤、中风、动脉粥样硬化、高血压和所有其他氧化剂诱发的组织损伤或伤害的治疗剂。